Forskolin versus sodium cromoglycate for prevention of asthma attacks: a single-blinded clinical trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16749416
Conclusion of this study
Values of forced expiratory volume in 1 s and forced expiratory flow, mid-phase, A similar in the two groups during the treatment period. We conclude that forskolin is more effective than sod cromoglycate in preventing asthma attacks in patients with mild persistent or moderate persistent asthma.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study